Amgen (AMGN) PT Raised to $304 at BofA Securities

January 13, 2026 5:35 AM EST Send to a Friend
BofA Securities analyst Tim Anderson raised the price target on Amgen (NASDAQ: AMGN) to $304.00 (from $272.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login